CDSCO

KT 18 May 2021.00_44_36_15.Still002

‘B.1.617.2 May Be 50% More Contagious Than Variant First Seen in UK’

Karan Thapar 19/05/2021

Gagandeep Kang said B.1.617.2 is a key component of...

kvr_vkp_bb

COVID in India: 35 Questions for K. VijayRaghavan, V.K. Paul and Balram Bhargava

Karan Thapar 30/04/2021

The government's top scientists have been giving interviews and...

COVID-19 vaccination in Mumbai

Bharat Biotech To See if Third Covaxin Dose Can Provide Protection for Longer

The Wire Staff 02/04/2021

The subject expert committee of the country's top drug...

COVID-19 vaccination in New Delhi

Brazil’s Health Regulator Anvisa Says Covaxin Doesn’t Meet Manufacturing Standards

The Wire Staff 30/03/2021

The Brazil government had signed a contract with Precis...

ajay bhalla

Home Secy Ajay Bhalla Asks States To Prosecute People for Vaccine Safety ‘Rumours’

Vasudevan Mukunth 25/01/2021

The instruction effectively attempts to tip the scales of...

Screen Shot 2021-01-05 at 6.31.26 PM

Watch | ‘Why Authorise a Vaccine Without Phase 3 Efficacy?’: Gagandeep Kang

Karan Thapar 06/01/2021

India’s top vaccine scientist says the process of approval...

A paramedic fills a syringe with a vaccine against the coronavirus disease (COVID-19) before administering it to a health worker during its trials at Civil Hospital in Ahmedabad

Bharat Biotech, Serum Institute End Spat, Pledge ‘Smooth Rollout’ of Vaccines

Devjyot Ghoshal and Sachin Ravikumar 05/01/2021

Both the Indian vaccine makers had clashed over the...